Analyst Price Target is GBX 0
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Inspiration Healthcare Group in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a -100.00% upside from the last price of GBX 114.
Current Consensus is
The current consensus among 0 contributing investment analysts is to n/a stock in Inspiration Healthcare Group. This rating has held steady since April 2021, when it changed from a Buy consensus rating.
Inspiration Healthcare Group
Inspiration Healthcare Group plc, together with its subsidiaries, provides medical devices for use in critical care, operating theatre, and home healthcare applications worldwide. The company offers neonatal intensive care products, such as inspiration air/oxygen blenders; Tecotherm Neo, a servo control device for total body cooling and warming to monitor the infant's temperature for every 2 seconds and making minute changes to the cooling fluid to ensure that the infant's temperature remains stable; LifeStart, a neonatal bedside resuscitation unit; and Inspire rPAP, a 2-piece non-invasive system for the initial stabilization and resuscitation of infants. It also provides adult intensive care products; AlphaCore5, a patient warming system for the prevention of inadvertent hypothermia; and CosyTherm2, a patient warming system for the management of body temperature in neonates. In addition, the company provides respiratory disposables for premature and sick babies. Further, it is involved in the distribution of third party products, including infusion therapy products for parenteral feeding and chemotherapy applications; and provision of technology support services. Inspiration Healthcare Group plc was incorporated in 1998 and is headquartered in Crawley, the United Kingdom.